Ignite Planners’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-5,762
Closed -$739K 420
2025
Q3
$739K Sell
5,762
-208
-3% -$25.4K 0.12% 167
2025
Q2
$682K Buy
5,970
+174
+3% +$19.6K 0.12% 170
2025
Q1
$645K Buy
5,796
+72
+1% +$7.67K 0.13% 163
2024
Q4
$559K Buy
5,724
+235
+4% +$25.1K 0.12% 154
2024
Q3
$631K Sell
5,489
-93
-2% -$10.6K 0.14% 138
2024
Q2
$604K Buy
5,582
+256
+5% +$25.7K 0.15% 138
2024
Q1
$511K Sell
5,326
-1,015
-16% -$104K 0.14% 149
2023
Q4
$640K Sell
6,341
-588
-8% -$56.8K 0.19% 130
2023
Q3
$666K Buy
+6,929
New +$703K 0.2% 129

Other funds holding NVS

Ignite Planners's NVS Position: Q4 2025 in Review

Ignite Planners sold out of Novartis (NVS) in Q4 2025, closing a stake of 5,762 shares — an estimated $739K sold.

Ignite Planners first reported a position in NVS in Q3 2023 and held it in 9 quarters. The position peaked at $739K in Q3 2025. 1,510 funds tracked by Wall St. Rank hold NVS as of Q4 2025.

  • Ignite Planners reported no remaining Novartis position as of Q4 2025 after selling out during the quarter.
  • Ignite Planners sold 5,762 Novartis shares in Q4 2025, an estimated $739K.
  • Ignite Planners first reported a position in Novartis in Q3 2023 and held it in 9 quarters.
  • Ignite Planners's Novartis position peaked at $739K in Q3 2025.
  • 1,510 funds tracked by Wall St. Rank held Novartis as of Q4 2025.

Based on Ignite Planners's 13F filing for Q4 2025, filed 6 Feb 2026.